Urinary tract infections vaccine - Sequoia Sciences

Drug Profile

Urinary tract infections vaccine - Sequoia Sciences

Alternative Names: UTI vaccine - Sequoia Sciences

Latest Information Update: 28 Jul 2017

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Sequoia Sciences
  • Class Vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Urinary tract infections

Most Recent Events

  • 26 Jul 2017 Phase-I clinical trials in Urinary tract infections (Recurrent, In adults) in USA (unspecified route) prior to June 2017
  • 26 Jul 2017 Urinary tract infections vaccine - Sequoia Sciences receives Fast Track designation for Urinary tract infections (Recurrent) in USA
  • 26 Jul 2017 Sequoia Sciences completes a phase I clinical trial in Urinary tract infections prior to July 2017
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top